Skip to main content
. 2012 Aug 1;103(9):1665–1671. doi: 10.1111/j.1349-7006.2012.02359.x

Figure 1.

Figure 1

IC 50 values for everolimus of nine triple‐negative breast cancer (TNBC) cell lines. Each cell line was treated with the indicated concentrations of everolimus for 96 h. Viable cell numbers were relatively quantified using the CCK‐8 assay and were expressed as a percent of the untreated control.